This company listing is no longer active
CStone Pharmaceuticals Management
Management criteria checks 1/4
CStone Pharmaceuticals' CEO is Jason Yang, appointed in Aug 2022, has a tenure of 1.58 years. total yearly compensation is CN¥61.90M, comprised of 4.1% salary and 95.9% bonuses, including company stock and options. directly owns 0.88% of the company’s shares, worth HK$12.70M. The average tenure of the management team and the board of directors is 1.6 years and 5 years respectively.
Key information
Jason Yang
Chief executive officer
CN¥61.9m
Total compensation
| CEO salary percentage | 4.1% |
| CEO tenure | 1.6yrs |
| CEO ownership | 0.9% |
| Management average tenure | 1.6yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -CN¥750m |
| Mar 31 2023 | n/a | n/a | -CN¥827m |
| Dec 31 2022 | CN¥62m | CN¥3m | -CN¥903m |
Compensation vs Market: Jason's total compensation ($USD8.60M) is above average for companies of similar size in the Hong Kong market ($USD344.14K).
Compensation vs Earnings: Insufficient data to compare Jason's compensation with company performance.
CEO
Jason Yang (59 yo)
1.6yrs
Tenure
CN¥61,895,000
Compensation
Dr. Jianxin Yang, M.D., Ph D., also known as Jason, is Senior Vice President and Chief Medical Officer of CStone Pharmaceuticals December 2016 and has been Chief Executive Officer since August 25, 2022. In...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Senior VP & Chief Medical Officer | 1.6yrs | CN¥61.90m | 0.88% HK$ 12.7m | |
| Vice President of Finance | no data | no data | no data | |
| Senior VP & Chief Scientific Officer | no data | no data | no data | |
| Chief Commercial Officer & Chief Strategy Officer | 2.8yrs | no data | no data | |
| Joint Company Secretary | 1.7yrs | no data | no data | |
| Joint Company Secretary | 1.2yrs | no data | no data |
1.6yrs
Average Tenure
48yo
Average Age
Experienced Management: 2616's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Member of Scientific Advisory Board | 5yrs | no data | no data | |
| Independent Non-Executive Director | 5.1yrs | CN¥269.00k | no data | |
| Non-Executive Director | 3.3yrs | no data | no data | |
| Independent Non-Executive Director | 5.1yrs | CN¥673.00k | no data | |
| Non Executive Director | 2.3yrs | CN¥399.00k | no data | |
| Member of Scientific Advisory Board | 4.8yrs | no data | no data | |
| Independent Non-Executive Director | 5.1yrs | CN¥269.00k | no data | |
| Non-Executive Chairman | 8.3yrs | no data | no data | |
| Non-Executive Director | 2.7yrs | no data | no data |
5.0yrs
Average Tenure
61yo
Average Age
Experienced Board: 2616's board of directors are considered experienced (5 years average tenure).